⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for ovarian serous tumor

Every month we try and update this database with for ovarian serous tumor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal CancerNCT02446600
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Seromuc...
Ovarian Serous ...
Ovarian Transit...
Ovarian Undiffe...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Prima...
Biospecimen Col...
Carboplatin
Cediranib Malea...
Computed Tomogr...
Echocardiograph...
Gemcitabine
Gemcitabine Hyd...
Laboratory Biom...
Magnetic Resona...
Multigated Acqu...
Olaparib
Paclitaxel
Pegylated Lipos...
Pharmacological...
Quality-of-Life...
18 Years - National Cancer Institute (NCI)
Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian CancerNCT02520115
Adnexal Mass
Borderline Ovar...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Neoplas...
Ovarian Serous ...
Recurrent Ovari...
Dexamethasone
Laboratory Biom...
Valproic Acid
18 Years - Barbara Ann Karmanos Cancer Institute
Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube CancerNCT02595892
Ovarian Serous ...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Berzosertib
Gemcitabine
Gemcitabine Hyd...
18 Years - National Cancer Institute (NCI)
Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube CancerNCT02595892
Ovarian Serous ...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Berzosertib
Gemcitabine
Gemcitabine Hyd...
18 Years - National Cancer Institute (NCI)
Auranofin and Sirolimus in Treating Participants With Ovarian CancerNCT03456700
Ovarian Serous ...
Recurrent Ovari...
Auranofin
Laboratory Biom...
Sirolimus
18 Years - Mayo Clinic
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: